EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 37 / Numéro 4 (Avril 2021) Med Sci (Paris), 37 4 (2021) 342-348 Références
Open Access
Numéro
Med Sci (Paris)
Volume 37, Numéro 4, Avril 2021
Page(s) 342 - 348
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2021031
Publié en ligne 28 avril 2021
  1. O’Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol 2016 ; 16 : 553–565. [CrossRef] [PubMed] [Google Scholar]
  2. Si-Tahar M, Touqui L, Chignard M. Innate immunity and inflammation–two facets of the same anti-infectious reaction. Clin Exp Immunol 2009 ; 156 : 194–198. [CrossRef] [PubMed] [Google Scholar]
  3. Li Z, Quan G, Jiang X, et al. Effects of metabolites derived from gut microbiota and hosts on pathogens. Front Cell Infect Microbiol 2018 ; 8 : 314. [CrossRef] [PubMed] [Google Scholar]
  4. Luan HH, Medzhitov R. Food fight: role of itaconate and other metabolites in antimicrobial defense. Cell Metab 2016 ; 24 : 379–387. [CrossRef] [PubMed] [Google Scholar]
  5. McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity 2014 ; 41 : 36–48. [CrossRef] [PubMed] [Google Scholar]
  6. Ayres JS. Immunometabolism of infections. Nat Rev Immunol 2020; 20 : 79–80. [CrossRef] [PubMed] [Google Scholar]
  7. Grolla AA, Travelli C, Genazzani AA, et al. Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine. Br J Pharmacol 2016 ; 173 : 2182–2194. [CrossRef] [PubMed] [Google Scholar]
  8. Krawczyk CM, Holowka T, Sun J, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010 ; 115 : 4742–4749. [CrossRef] [PubMed] [Google Scholar]
  9. Dorneles GP, Dos Passos AAZ, Romão PRT, et al. New insights about regulatory t cells distribution and function with exercise: the role of immunometabolism. Curr Pharm Des 2020; 26 : 979–90. [CrossRef] [PubMed] [Google Scholar]
  10. McElvaney OJ, McEvoy N, McElvaney OF, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med 2020; 202 : 812–21. [CrossRef] [PubMed] [Google Scholar]
  11. Rodríguez-Prados JC, Través PG, Cuenca J, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 2010 ; 185 : 605–614. [CrossRef] [PubMed] [Google Scholar]
  12. Van den Bossche J, Baardman J, de Winther MPJ. Metabolic characterization of polarized m1 and m2 bone marrow-derived macrophages using real-time extracellular flux analysis. J Vis Exp 2015 ; 105 : 53424. [Google Scholar]
  13. Palsson-McDermott EM, O’Neill LAJ. The Warburg effect then and now: from cancer to inflammatory diseases. BioEssays 2013 ; 35 : 965–973. [CrossRef] [PubMed] [Google Scholar]
  14. Van den Bossche J, O’Neill LA, Menon D. Macrophage immunometabolism: where are we (going)?. Trends Immunol 2017 ; 38 : 395–406. [CrossRef] [PubMed] [Google Scholar]
  15. Jha AK, Huang SCC, Sergushichev A, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 2015 ; 42 : 419–430. [CrossRef] [PubMed] [Google Scholar]
  16. Lampropoulou V, Sergushichev A, Bambouskova M, et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab 2016 ; 24 : 158–166. [CrossRef] [PubMed] [Google Scholar]
  17. Guillon A, Arafa EI, Barker KA, et al. Pneumonia recovery reprograms the alveolar macrophage pool. JCI Insight 2020; 5 : e133042. [Google Scholar]
  18. Zhang Y, Zhang Y, Sun K, et al. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development. J Mol Cell Biol 2018 ; 11 : 1–13. [Google Scholar]
  19. Soto-Heredero G, Gómez de Las Heras MM, Gabandé-Rodríguez E, et al. Glycolysis - a key player in the inflammatory response. FEBS J 2020; 287 : 3350–69. [CrossRef] [PubMed] [Google Scholar]
  20. Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell 2017 ; 168 : 960–976. [CrossRef] [PubMed] [Google Scholar]
  21. Linke M, Fritsch SD, Sukhbaatar N, et al. mTORC1 and mTORC2 as regulators of cell metabolism in immunity. FEBS Lett 2017 ; 591 : 3089–3103. [CrossRef] [PubMed] [Google Scholar]
  22. Sinclair LV, Rolf J, Emslie E, et al. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol 2013 ; 14 : 500–508. [CrossRef] [PubMed] [Google Scholar]
  23. Klysz D, Tai X, Robert PA, et al. Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation. Sci Signal 2015; 8 : ra97. [CrossRef] [PubMed] [Google Scholar]
  24. Tannahill G, Curtis A, Adamik J, et al. Succinate is a danger signal that induces IL-1β via HIF-1α. Nature 2013 ; 496 : 238–242. [CrossRef] [PubMed] [Google Scholar]
  25. Littlewood-Evans A, Sarret S, Apfel V, et al. GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. J Exp Med 2016 ; 213 : 1655–1662. [CrossRef] [PubMed] [Google Scholar]
  26. Zhang Q, Cao X. Epigenetic regulation of the innate immune response to infection. Nat Rev Immunol 2019 ; 19 : 417–432. [CrossRef] [PubMed] [Google Scholar]
  27. Domínguez-Andrés J, Joosten LA, Netea MG. Induction of innate immune memory: the role of cellular metabolism. Curr Opin Immunol 2019 ; 56 : 10–16. [CrossRef] [PubMed] [Google Scholar]
  28. Balmer ML, Ma EH, Bantug GR, et al. Memory CD8+ T cells require increased concentrations of acetate induced by stress for optimal function. Immunity 2016 ; 44 : 1312–1324. [CrossRef] [PubMed] [Google Scholar]
  29. Mills EL, Ryan DG, Prag HA, et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 2018 ; 556 : 113–117. [CrossRef] [PubMed] [Google Scholar]
  30. Furuse Y.. Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers. Proc Natl Acad Sci USA 2019 ; 116 : 478–483. [Google Scholar]
  31. Mathers C. Global burden of disease. In: International Encyclopedia of Public Health. New York : Elsevier, 2017 : 256–67. [Google Scholar]
  32. Naujoks J, Tabeling C, Dill BD, et al. IFNs Modify the proteome of Legionella-containing vacuoles and restrict infection via IRG1-derived itaconic acid. PLoS Pathog 2016 ; 12 : e1005408. [CrossRef] [PubMed] [Google Scholar]
  33. Nguyen TV, Alfaro AC, Young T, et al. Itaconic acid inhibits growth of a pathogenic marine vibrio strain: a metabolomics approach. Sci Rep 2019 ; 9 : 5937. [CrossRef] [PubMed] [Google Scholar]
  34. Cheah HL, Lim V, Sandai D. Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents. PLoS One 2014 ; 9 : e95951. [CrossRef] [PubMed] [Google Scholar]
  35. Peng B, Su Y, Li H, et al. Exogenous alanine and/or glucose plus kanamycin kills antibiotic-resistant bacteria. Cell Metabol 2015 ; 21 : 249–262. [Google Scholar]
  36. Fisher RA, Gollan B, Helaine S. Persistent bacterial infections and persister cells. Nat Rev Microbiol 2017 ; 15 : 453–464. [CrossRef] [PubMed] [Google Scholar]
  37. Crabbé A, Ostyn L, Staelens S, et al. Host metabolites stimulate the bacterial proton motive force to enhance the activity of aminoglycoside antibiotics. PLoS Pathog 2019 ; 15 : e1007697. [CrossRef] [PubMed] [Google Scholar]
  38. Allison KR, Brynildsen MP, Collins JJ. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 2011 ; 473 : 216–220. [CrossRef] [PubMed] [Google Scholar]
  39. Daniels BP, Kofman SB, Smith JR, et al. The nucleotide sensor ZBP1 and kinase RIPK3 induce the enzyme IRG1 to promote an antiviral metabolic state in neurons. Immunity 2019 ; 50 : 64–76. [CrossRef] [PubMed] [Google Scholar]
  40. de Almeida GMF, Silva LCF, Colson P, et al. Mimiviruses and the human interferon system: viral evasion of classical antiviral activities, but inhibition by a novel interferon-β regulated immunomodulatory pathway. J Interferon Cytokine Res 2017 ; 37 : 1–8. [CrossRef] [PubMed] [Google Scholar]
  41. Sethy B, Hsieh CF, Lin TJ, et al. Design, synthesis, and biological evaluation of itaconic acid derivatives as potential anti-influenza agents. J Med Chem 2019 ; 62 : 2390–2403. [CrossRef] [PubMed] [Google Scholar]
  42. Kim CH. Immune regulation by microbiome metabolites. Immunology 2018 ; 154 : 220–229. [CrossRef] [PubMed] [Google Scholar]
  43. Libertucci J, Young VB. The role of the microbiota in infectious diseases. Nat Microbiol 2019 ; 4 : 35–45. [CrossRef] [PubMed] [Google Scholar]
  44. Razungles J, Cavaillès V, Jalaguier S, Teyssier C. L’effet Warburg : de la théorie du cancer aux applications thérapeutiques en cancérologie. Med Sci (Paris) 2013 ; 29 : 1026–1033. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  45. Julien LA, Roux PP. mTOR, la cible fonctionnelle de la rapamycine. Med Sci (Paris) 2010; 26 :1056–60. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  46. Torre C. Laure Tsoumtsa L, Ghigo E. La mémoire immunitaire entraînée chez les invertébrés : que sait-on ?. Med Sci (Paris) 2017 ; 33 : 979–983. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.